BoomRay Pharmaceuticals is at the forefront of creating next-generation targeted radionuclide-conjugated drugs. HongShan led this round, with participation from Riverhead Capital, Tririver Capital, Puhua Capital, Tsing Song Capital, Life Sciences Investme
Raintech, a leading smart IoT production management platform for greenhouses, announced the successful closing of its Series A financing, with Shunwei Capital investing millions of RMB. The funds will be primarily used for product research and development
Therorna Inc. is dedicated to the development of novel vaccines and therapies in multiple cutting-edge treatment areas, focusing on international frontier circular RNA (circRNA) technology. This funding round was led by MSA Capital and a renowned industri
Sihuan Pharm announced that its non-wholly-owned subsidiary, Huisheng Pharm, has completed a RMB 500 million Series A financing. This round was invested by China Life Chengda (Shanghai) Health Industry Equity Investment Centre (L.P.), GF Investment, GF In
Senlang Biotechnology announced the successful closing of RMB 200 million from Qianhai Ark Asset Management. CEC Capital Group acted as the exclusive financial advisor for Senlang Biotechnology in this transaction.
Yunsilicon announced the acquisition of another hundred million RMB in investment. This round was led by Lightspeed China Partners, with strategic investment from MorethanMoore, a subsidiary fund under the National IC Industry Investment Fund, and partici
DataMesh, the digital twin platform provider, has recently achieved a successful completion of its B2 round financing. The funds secured in this round are predominantly designated for the development of enterprise metaverse products and the expansion into